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Purpose of review
Considerable uncertainty and controversy has existed concerning the
management of convergence insufficiency. Only recently there have been
significant scientific studies published that compare the effectiveness of the
commonly prescribed treatments. This paper reviews the most recent
research and literature on convergence insufficiency and its treatment.
Recent findings
The first large-scale placebo-controlled, randomized clinical trials to study
the various treatments of convergence insufficiency have recently been
published. Current research compares the effectiveness of base-in prism
glasses, pencil push-ups, and vision therapy in reducing the signs and

symptoms of convergence insufficiency and suggests that orthoptic therapy
is the most efficacious treatment for convergence insufficiency.
Summary
Intensive orthoptic therapy is the treatment of choice for convergence
insufficiency. Pencil push-ups and use of accommodative targets have a role
in the treatment of convergence insufficiency when used as part of a more
intensive orthoptic program. Base-in prism glasses should be reserved for
reduction of symptoms in the presbyopic population.
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Introduction
In the evaluation of patients with ocular asthenopia, convergence
insufficiency should be a part of the differential diagnosis. As convergence
insufficiency is the most frequent cause for muscular discomfort it is of
considerable clinical significance [1,2]. This condition is characterized
by a patient’s inability to converge the eyes smoothly and effectively as the
object of visual interest moves from distance to near and/or the inability to
maintain the convergent near point. This ineffective muscular action can
cause loss of proper binocular alignment with a resultant exophoria or
intermittent exotropia at near. Associated with convergence insufficiency is
a wide range of symptoms that can vary from mild to severe. Patients can be
particularly distressed when they experience binocular diplopia at near.
Historically the treatment for convergence insufficiency, especially vision
therapy, has created controversy in both the ophthalmic and optometric
communities [3_,4,5]. There has been a lack of consensus regarding the
most beneficial treatment. Until recently, there had been a
paucity of good scientific study. This paper reviews the etiology,
symptomatology, diagnosis and most recent findings in the treatment of
convergence insufficiency.

Etiology and prevalence
In 1855, von Graefe first described the symptoms of convergence
insufficiency and thought it to be myogenic in origin [6,7]. In the recent
past, convergence insufficiency was considered by some ophthalmologists to
be a syndrome of asthenopic symptoms that, although manageable with
orthoptic therapy, was thought to be psychogenic in origin and not curable
because of the associated neuroses [1]. These views on etiology have not
withstood the test of time. Our current understanding suggests an
innervational etiology because of the frequent dramatic response to
treatment both in the patient’s subjective improvement as well as the
objective measurements of near point of convergence and fusional
convergence amplitudes [8].
The current reports sight a frequency of convergence insufficiency between
2.25 and 8.3% but these numbers originate from clinical studies on schoolage children and university students [9]. Earlier reports find that incidence
data varies from 1 to 25% [2]. Further study needs to be done to define the
prevalence of this entity and determine if there is a familial predisposition as
seen in other strabismic conditions.
Symptoms
The symptoms of convergence insufficiency can be highly variable. Some
patients can have a significant convergence insufficiency and exhibit very
few complaints. Others can have a very minimal convergence insufficiency
and have severe symptoms. Most symptoms of convergence insufficiency
are directly related to reading or other near tasks. The symptoms occur when
there is an attempt at fusion and binocularity is present. Patients with
monofixation syndrome are less likely to be symptomatic. Similar to many
strabismic conditions, the symptoms of convergence insufficiency can be
aggravated by stress, illness or lack of sleep. Patients typically present with
one or many of the following complaints:
Headaches – The headache can occur during reading or after long periods of
reading or, in my experience, may occur even without specific near tasks.
The headaches are frequently located in the frontal area or are periocular.
They are the result of the sustained effort to increase fusional convergence.
The resultant headache from convergence insufficiency can potentiate other
underlying headaches such as migraines.

Asthenopia – This can manifest as tired, strained eyes or eyes that hurt or
feel sore with near work. Some patients may indicate that something is
wrong with their eyes but will be vague or indefinite in their description of
the problem. Patients also describe a pulling or pressure sensation around the
eyes. These complaints result from the increased convergence and/or
accommodative effort needed to maintain convergence.
Difficulty with reading or near tasks -Patients will describe intermittent
blurriness of words, print moving on the page, frequently loosing their place,
lack of concentration or difficulty with comprehension while reading.
Difficulty with reading for longer periods of time is common as the
symptoms worsen with increased time at the near task. Some patients will
not describe symptoms at near simply because of their strong avoidance of
near vision tasks.
Diplopia – This can present as two distinct images or an overlap of images.
In convergence insufficiency, the images are horizontally displaced. Many
patients will have difficulty deciphering the double images and will
complain of blurriness of their vision. Some patients will close one eye to
read to relieve the diplopia. Proper testing can further delineate the
complaint related to diplopia as it will resolve with monocular acuity testing.
Diplopia usually results from the related exodeviation at near seen with
convergence insufficiency, but other forms of underlying strabismic
tendency (e.g., esophoria) can become ‘uncovered’ when fusion is disrupted.
Clinical findings
The diagnosis of convergence insufficiency is based on the symptomatology
as well as the physical findings. If the patient exhibits suppression then they
may show many abnormal clinical findings without any of the symptoms
discussed. The patient with convergence insufficiency may have an
abnormality in any one or all of the following clinical findings:
Remote near point of convergence
A remote near point of convergence is the most consistent finding in
convergence insufficiency (Fig. 1—AT END OF ARTICLE). There is little
general consensus on what constitutes a normal near point. Clinical
experience reveals that this measurement can be variable between patients.

Normal young children have an excellent ability to converge and can
maintain convergence easily 1–2 cm from their nasal bridge. Adults have
slightly more difficulty but normally can maintain convergence in the 3–4
cm range. Many authors use a remote near point of 10 cm to define patients
with convergence insufficiency. The Convergence Insufficiency Treatment
Trial (CITT) is using at least 6 cm as their inclusion criteria for their
treatment studies. However, the child or adult with significant symptoms and
other findings consistent with convergence insufficiency can have a receded
near point as little as 4–5 cm from the nasal bridge. With careful observation
one may see the patient with convergence insufficiency to have increased
effort with convergence long before the near point is achieved. This can
manifest as a slow and/or jerking movement, rather than the smooth
consistent movement seen in normal convergence, or the development of an
exodeviation with prolonged maintenance at a near point in excess of the
patient’s capability. The abnormalities of convergence insufficiency are
most easily seen while measuring near point of convergence using an
accommodative target.
Decreased fusional convergence
The stimulus for fusional convergence at near is disparate retinal imagery
[10]. Fusional convergence amplitudes or positive fusional vergence is the
amount of convergence available to overcome temporal disparity in order to
maintain binocular fusion at near. Base-out prisms are used to measure
fusional convergence. To accomplish this measurement, the patient is
instructed to keep a line of Snellen letters single and clear as base-out prism
is added in a slow, gradual manner. Diplopia will occur when fusion is no
longer possible. The amount of prism added to cause diplopia is the
measurement of fusional convergence. The prism can then be reduced until
fusion is re-established. This amount of prism is the recovery
point.
In convergence insufficiency it is common to see low fusional convergence
amplitudes and thus an inability to maintain near fixation. The recovery
point at which fusion is re-established after being broken can also be
an indicator of fusional potential. As with low convergence amplitudes the
recovery point will be receded as well.

Phoria or tropia
Most patients with convergence insufficiency will demonstrate varying
degrees of exophoria or even an intermittent exotropia at near. The presence
of orthophoria at near does not rule out convergence insufficiency.
Some patients will have reduced stereoacuity at near. With distance fixation
patients may have a small exophoria or be orthophoric.
Treatment for convergence insufficiency
Realizing the fact that not all patients with convergence insufficiency are
symptomatic is important. Treatment for asymptomatic patients is generally
unnecessary. Prescribed treatments for symptomatic patients include
base-in prism reading glasses, pencil push-ups, orthoptics, vision therapy,
and office-based vergence/accommodative therapy.
Recently, the CITT Study Group is a collaborative multicenter effort and
started the first large-scale placebo-controlled, randomized clinical trials to
study the various treatments of convergence insufficiency [11,12]. This
group also developed the Convergence Insufficiency Symptom Survey to
quantify the severity of symptoms of convergence insufficiency to aid
further study [13].
Base-in prism reading glasses
Although base-in prism reading glasses have been used commonly to give
symptomatic improvement in convergence insufficiency, there has been little
scientific evidence to support its efficacy. Recently two studies have
presented data, one in children and one in presbyopes [14,15_].
The CITT Study Group found that base-in reading glasses were more
effective than placebo reading glasses in improving symptoms and signs of
convergence insufficiency in children aged 9 through 17 years. This study
found that base-in prism reading glasses were no more effective than
placebo reading glasses in relieving the symptoms of convergence
insufficiency in children. Neither treatment group showed clinically
significant changes in the near point of convergence or positive fusional
convergence at near. The potential limitations of the study were the method
of calculating the magnitude of the prism and the length of follow-up which
was only 6 weeks.

In symptomatic presbyopic adults aged 45–68 years, base-in prism was
effective in decreasing symptomatology related to convergence
insufficiency. One limitation of the study was the design of the prism glasses
(not a commercially available option). This design had only a small range in
the amount of prism that could be placed at near. Therefore additional prism
was placed at both distance and near in some subjects. Whether the prism at
distance induced some asthenopia or if possible prism adaptation occurred in
some subjects was unclear and not controlled in this study.
Pencil push-ups/accommodative target
Pencil push-ups have been used as a mainstay of treatment for convergence
insufficiency in both the optometric and ophthalmic communities. With
pencil push-ups, the patient is instructed to maintain single
vision as a target (commonly the pencil tip or eraser) is moved toward his or
her nose. Many believe that an accommodative target (e.g., a letter or a
picture with fine detail) should be used to facilitate accommodation
and, hence, fusional convergence. Because of this, many use the letters on
the pencil for fixation during pencil push-ups. Despite their frequent use,
there have been very limited studies evaluating their effectiveness.
A pilot study was performed prior to further studies by the CITT Study
Group. This prospective, noncontrolled study evaluated the efficacy of
pencil push-ups to determine if they could measurably change symptoms
and findings in convergence insufficiency [16]. Although the study was
inherently flawed by its design, it did show that pencil push-ups somewhat
improved the near point of convergence and the positive fusional
vergence.
Further research from the CITT Study Group compared pencil push-ups to
vision therapy/orthoptics and placebo vision therapy/orthoptics [9]. This
study found that pencil push-ups were not effective in improving either the
symptoms or signs associated with convergence insufficiency, and no more
effective than placebo. Criticism of the study points out that pencil push-ups
are rarely prescribed as the sole treatment for convergence insufficiency
and are frequently prescribed as part of a more intensive orthoptic program
[17]. The pencil push-ups in the study were performed using the tip of the
sharpened pencil as the fixation target. Critics contend that an
accommodative target is more frequently used to facilitate fusional
convergence and that sustenance of convergence is important while doing

the exercises [18]. Recent research has shown that sustained convergence
does alter phorias and divergence dynamics [19]. Both an accommodative
target and sustained convergence would intensify the pencil push-up therapy
and may make it a more effective treatment.
Orthoptic therapy/vision therapy/computer orthoptics
‘Vision therapy’ has been one of the most controversial treatments for
convergence insufficiency. Unfortunately, the term ‘vision therapy’ has
come to include many types of intervention used for a wide variety of
disorders including the underachieving child, reduction of myopia,
sports issues, neurological disorders, and others, with lack of scientific
support for these treatments [3_,20]. Despite these misapplications, there is
recent strong and persuasive scientific data in the literature to support the
use of some aspects of vision therapy for the treatment of convergence
insufficiency [21–24,25__]. Standard vision therapy for convergence
insufficiency, involving only orthoptic exercises, which includes
vergence/accommodative therapy, can be accomplished on various
computerized orthoptic programs. Other forms of ‘vision therapy’, including
yoked prisms, low-plus lenses, colored or tinted lenses, biofeedback visual
training, and others, are not treatments for convergence insufficiency.
To differentiate orthoptic treatments under the global term ‘vision therapy,’
the use of the term orthoptic therapy or computer orthoptics will be used in
this discussion. In the most current, widely used computer orthoptic
program, the HTS Home Computer Therapy System (Computer Orthoptics,
Gold Canyon, Arizona, USA), the patient is led through a series of exercises
including saccades, pursuits, base-in and base-out stereograms, jump
ductions and accommodation
The CITT found that office-based orthoptic therapy/computer orthoptics is
more effective than home-based pencil push-ups and placebo therapies in
children 9–18 years old [9]. Their subsequent study showed that 12 weeks of
office-based orthoptic therapy with home reinforcement resulted in greater
improvement in symptoms and clinical measurements when compared with
home-based pencil push-ups, home-based computer orthoptics and pencil
push-ups, and office-based placebo therapy [26].
They also noted that children maintained their improvements in symptoms
and signs for at least 1 year after discontinuing treatment [27_]. Further
publication reviews and compares the results of all CITT trials and

concludes that office-based orthoptic therapy/computer orthoptics is
significantly more effective than home-based or placebo therapies [25__].
As other authors critique the work of the CITT Study Group they indicate
that there are several issues for concern. The study groups were not equal in
their treatments [17,28–30]. The in-office group being treated with
orthoptics also had true home reinforcement and the placebo group did not.
Also, the intensity of the officebased orthoptic therapy far surpassed the
specific homebased orthoptic program. Yet, reviewing the current
research and the subsequent editorials indicates that an intensive orthoptic
program of some type can significantly reduce both the signs and symptoms
of convergence insufficiency.
A recent retrospective study showed that computer orthoptics delivered by
the HTS system, the same system used for home-based therapy in the CITT
trials, resulted in significant improvement in fusional amplitudes
and pretherapy symptoms [31]. This study included patients prescribed the
HTS program for a presumed accommodative/vergence disorder. The
researchers were unclear as to the specific diagnosis thatwas being treated as
they assessed the data from patient questionnaires via the internet. They
concluded that office-based orthoptic treatment is not always practical,may
be too expensive and may not be locally available. A home-based orthoptic
program offers a cost-effective reasonable alternative.
Conclusion
Current research clarifies the efficacy of some long-standing treatments and
indicates the potential for newer interventions such as home-based computer
programs. An intensive orthoptic program appears to be the treatment
of choice for reducing the signs and symptoms of convergence insufficiency.
What is unclear from the current studies and editorials is the amount of time
required to perform the therapy and the duration of treatment needed for
successful and complete treatment of this entity. Additional studies are also
needed to evaluate the treatment protocol for other age groups
beyond 18 and less than 9 years. There appears to be a role for pencil pushups or accommodative targets in the treatment of convergence insufficiency
when performed as part of a more intensive orthoptic program.

Base-in prism glasses appear to be useful in decreasing the symptoms of
convergence insufficiency in the presbyopic population. There seems to be
little or no role of this therapy in the treatment of children age 9 through 17.
Further studies are needed to elucidate whether this is appropriate and
beneficial treatment for other age groups or for children who are resistant to
other treatment modalities.
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Figure 1 Remote near point of convergence

This child shows exotropia at near as her near point has exceeded her
ability to converge and maintain fusion. She was orthotropic for distance
targets.

